AI model predicts drug properties to speed up development
Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...
eWeek5h
‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
GEN - Genetic Engineering and Biotechnology News13h
Mount Sinai Launches AI Small Molecule Drug Discovery Center
The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...
Alphabet’s Isomorphic Labs raises $600 million to advance AI drug design
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
Winners and wishers: 8 potential Bay Area drug approvals coming this year
Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...
Investing15h
US Dollar Index (DXY)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...